Clinical trial

Study Evaluating TMI-005 in Active Rheumatoid Arthritis

NCT00095342

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE2

Study timeline

Registry last updated2009-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

TMI-005DRUG

Sponsors & collaborators

Wyeth is now a wholly owned subsidiary of Pfizerlead sponsor

Mapped research locations

MontrealQuebec, Canada1 IndianapolisIndiana, United States1 SyracuseNew York, United States1 SaskatoonSaskatchewan, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00095342 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.